Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_assertion type Assertion NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_head.
- NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_assertion description "[Our finding of wide expression of DR4/DR5 in ESFT in vivo, in combination with their high sensitivity to TRAIL in vitro and the reported lack of toxicity of TRAIL in mice and monkeys, suggests that TRAIL may be a novel effective agent in the treatment of ESFTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_provenance.
- NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_assertion evidence source_evidence_literature NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_provenance.
- NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_assertion SIO_000772 11289151 NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_provenance.
- NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_assertion wasDerivedFrom befree-20140225 NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_provenance.
- NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_assertion wasGeneratedBy ECO_0000203 NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_provenance.